Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure

Y Otaki, T Watanabe, D Kinoshita, M Yokoyama… - International journal of …, 2017 - Elsevier
Background Oxidative stress due to purine degradation is associated with the development
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction

K Watanabe, T Watanabe, Y Otaki, T Shishido… - ESC heart …, 2020 - Wiley Online Library
Aims Reactive oxygen species are reportedly involved in the mechanism underlying heart
failure with preserved ejection fraction (HFpEF); however, the disease pathophysiology …

[HTML][HTML] Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients

Y Fujimura, Y Yamauchi, T Murase, T Nakamura… - PLoS …, 2017 - journals.plos.org
Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine
catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase …

Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care

H Okazaki, A Shirakabe, M Matsushita… - ESC heart …, 2019 - Wiley Online Library
Aims Plasma xanthine oxidoreductase (XOR) activity during the acute phase of acute heart
failure (AHF) requires further elucidation. Methods and results One hundred eighteen AHF …

Uric acid in chronic heart failure

W Doehner, SD Anker - Seminars in nephrology, 2005 - Elsevier
The pathophysiologic understanding of chronic heart failure (CHF) has shifted from a mere
hemodynamic disorder to a much more complex approach including changes and …

Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition

A Harzand, L Tamariz, JM Hare - Congestive Heart Failure, 2012 - Wiley Online Library
Increasing evidence suggests that serum uric acid (UA), a product of xanthine oxidase (XO),
may be a useful marker for metabolic, hemodynamic, and functional staging in heart failure …

Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study

MM Givertz, KJ Anstrom, MM Redfield, A Deswal… - Circulation, 2015 - Am Heart Assoc
Background—Oxidative stress may contribute to heart failure (HF) progression. Inhibiting
xanthine oxidase in hyperuricemic HF patients may improve outcomes. Methods and …

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure

C Bergamini, M Cicoira, A Rossi… - European journal of …, 2009 - Wiley Online Library
Heart failure (HF) is a state of chronic deterioration of oxidative mechanisms due to
enhanced oxidative stress and consequent subcellular alterations. In this condition, oxidant …

The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study

HE Cingolani, JA Plastino, EM Escudero… - Journal of cardiac …, 2006 - Elsevier
BACKGROUND: Reactive oxygen species (ROS) have been linked to hypertrophy,
remodeling and abnormal excitation-contraction coupling. Previous data demonstrated that …

Uric acid and xanthine oxidase in heart failure—Emerging data and therapeutic implications

W Doehner, EA Jankowska, J Springer… - International journal of …, 2016 - Elsevier
The role of hyperuricaemia as cardiovascular risk factor has exhaustingly been debated for
decades. While the association of elevated uric acid (UA) levels with increased mortality risk …